This article is more than 5 years old. Information may no longer be current.

Late-breaking research highlights at AAD include vitiligo, psoriasis treatment

Late-breaking research presented at the American Academy of Dermatology Annual Meeting in Orlando, Florida, included vitiligo and research treatment.

Highlights included study results finding that epidermal graft harvesting was an effective alternative treatment for vitiligo and that Cimzia demonstrated efficacy at 16 weeks as psoriasis treatment:

Epidermal graft harvesting effective alternative treatment for vitiligo

ORLANDO, Fla. — An epidermal graft harvesting system was an effective alternative to split-thickness skin grafting in treating patients with vitiligo, according to research presented at a late-breaking research forum of the American Academy of Dermatology Annual Meeting.

“[The] epidermal harvesting system (cellutome) combines negative pressure and heat to form epidermal micrografts,” presenter Sanober Daruwalla, MBBS, of Mumbai, India, and colleagues reported. Read more

Tapinarof cream shows efficacy in treating plaque psoriasis

Tapinarof nonsteroidal anti-inflammatory topical cream, applied once or twice daily, showed efficacy in treating mild-to-moderate plaque psoriasis, according to late-breaking research presented at the American Academy of Dermatology Annual Meeting in Orlando, Florida.

Tomoko Maeda-Chubachi, MD, presented research on a randomized, evaluator-blinded study of 227 adults with psoriasis; about 80% of patients had mild-to-moderate plaque-type psoriasis. Read more

Cimzia demonstrates efficacy at 16 weeks as psoriasis treatment

ORLANDO, Fla. — Patients treated with Cimzia reported statistically significant improvement in moderate-to-severe plaque psoriasis at 16 weeks, according to research presented at a late-breaking research forum of the American Academy of Dermatology meeting.

“The 16-week primary results from CIMPASI-1 and CIMPASI-2 showed that treatment with Cimzia provided significant benefit to patients living with chronic plaque psoriasis, which is important given that the disease is historically difficult to treat and therefore requires multiple treatment options,” Alice Gottlieb, MD, PhD, professor of dermatology, Department of Dermatology, New York Medical College, at Metropolitan Hospital, who presented the data, stated in a press release from UCB and Dermira. Read more

Microneedling with tranexamic acid solution effectively treated rosacea

ORLANDO, Fla. — Microneedling with tranexamic acid solution was an effective treatment for women with erythematotelangiectatic rosacea, according to late-breaking research presented at the American Academy of Dermatology Annual Meeting.

Fotini Bageorgou, MD, reported on a study of 20 women, aged between 27 and 65 years, with erythematotelangiectatic rosacea. Read more

VIDEO: Long-term Dupixent plus topical corticosteroid treatment effective for AD

ORLANDO, Fla. —In a video perspective from the American Academy of Dermatology Annual Meeting, Andrew Blauvelt, MD, MBA, discusses his late-breaking research presentation on Dupixent with concomitant topical corticosteroids to treat moderate-to-severe atopic dermatitis.

Blauvelt, president of Oregon Medical Research Center, Portland, found that long-term treatment with Dupixent (dupilumab, Regeneron and Sanofi) plus topical corticosteroids improved atopic dermatitis signs and symptoms, including pruritus, with acceptable safety for up to 1 year when compared with topical corticosteroid treatment alone. Watch video